AP-1–driven memory enables adaptive cancer genome regulation

A Nature Perspective argues that cancer drug resistance can arise from adaptive cellular states learned by the AP-1 transcription factor network. By combinatorial AP-1 binding, stress-induced feedback, and epigenetic memory, AP-1 can reprogram the genome to create drug-tolerant states, effectively encoding a population-level memory that guides ongoing resistance and potentially informing broader biology beyond cancer.